Chaoju Eye Care Holdings Limited Share Price

Equities

2219

KYG2047K1094

Healthcare Facilities & Services

Market Closed - Hong Kong S.E. 01:38:20 26/04/2024 pm IST 5-day change 1st Jan Change
3.74 HKD +0.27% Intraday chart for Chaoju Eye Care Holdings Limited +4.76% -15.38%

Financials

Sales 2023 1.37B 189M 1.48B 15.76B Sales 2024 * 1.63B 225M 1.76B 18.73B Capitalization 2.34B 322M 2.52B 26.87B
Net income 2023 229M 31.6M 247M 2.64B Net income 2024 * 277M 38.23M 299M 3.19B EV / Sales 2023 1.98 x
Net cash position 2023 * - 0 0 0 Net cash position 2024 * - 0 0 0 EV / Sales 2024 * 1.43 x
P/E ratio 2023
12.2 x
P/E ratio 2024 *
8.73 x
Employees 1,428
Yield 2023 *
3.76%
Yield 2024 *
4.62%
Free-Float 48.91%
More Fundamentals * Assessed data
Dynamic Chart
Chaoju Eye Care Arms Ink Five Tenancy Deals in Inner Mongolia MT
Chaoju Eye Care Holdings Limited Announces Special Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024 CI
Chaoju Eye Care Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024 CI
Chaoju Eye Care Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Chaoju Eye Care Unit Invests 200 Million Yuan in Bank of China’s Structured Deposit Product MT
Chaoju Eye Care Holdings Limited commences an Equity Buyback for 70,762,500 shares, representing 10% of its issued share capital, under the authorization approved on June 6, 2023. CI
Chaoju Eye Care Holding Units Complete Purchase of 97% Stake in Beijing Eye Hospital MT
Chaoju Eye Care Plans Up to HK$100 Million Share Buyback; Shares Rise 5% MT
Chaoju Eye Care Holdings Limited Announces Resignation of Mr. Ke Xian as Non-Executive Director CI
Chaoju Eye Care Holdings Subsidiary Purchases 180 Million Yuan Worth of Structured Deposit Products MT
Chaoju Eye Care Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Chaoju Eye Care Sees Up to 52% Jump in H1 Profit MT
Chaoju Eye Care Holdings Limited Provides Consolidated Earning Guidance for the Six Months Ended June 30, 2023 CI
Chaoju Eye Care Holdings Limited Announces Change of Principal Place of Business in Hong Kong CI
Chaoju Eye Care Trustee Buys HK$2 Million of Shares Under Award Scheme MT
More news
1 day+0.27%
1 week+4.76%
Current month-4.83%
1 month-1.58%
3 months-1.06%
6 months-4.83%
Current year-15.38%
More quotes
1 week
3.58
Extreme 3.58
3.77
1 month
3.57
Extreme 3.57
4.01
Current year
3.50
Extreme 3.5
4.57
1 year
3.50
Extreme 3.5
5.68
3 years
2.60
Extreme 2.6
17.80
5 years
2.60
Extreme 2.6
17.80
10 years
2.60
Extreme 2.6
17.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 19/20/19
Director of Finance/CFO 42 01/18/01
Chief Operating Officer 54 01/17/01
Members of the board TitleAgeSince
Director/Board Member 44 19/20/19
Chief Executive Officer 61 19/20/19
Director/Board Member 62 -
More insiders
Date Price Change Volume
26/24/26 3.74 +0.27% 450,500
25/24/25 3.73 +1.91% 708,000
24/24/24 3.66 0.00% 743,000
23/24/23 3.66 +0.27% 523,000
22/24/22 3.65 +2.24% 623,500

Delayed Quote Hong Kong S.E., April 26, 2024 at 01:38 pm IST

More quotes
Chaoju Eye Care Holdings Limited is a China-based company principally engage in the provision of ophthalmic services and eye care services through hospitals and optical clinics. The Company operates its businesses through two segments. The Consumer Ophthalmic Services segment provides refractive correction (including presbyopia correction), myopia control and provides optical products and services. The Basic Ophthalmic Services segment provides treatments of a wide range of common eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases and pediatric eye diseases, which may be covered by public health insurance programs. The Company mainly conducts its businesses in the domestic market.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.462 CNY
Average target price
5.922 CNY
Spread / Average Target
+71.06%
Consensus

Annual profits - Rate of surprise